These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29865881)

  • 1. Monitoring Colistin Resistance in Food Animals, An Urgent Threat.
    Liu Y; Liu JH
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):443-446. PubMed ID: 29865881
    [No Abstract]   [Full Text] [Related]  

  • 2. MCR: modern colistin resistance.
    Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?
    Al-Tawfiq JA; Laxminarayan R; Mendelson M
    Int J Infect Dis; 2017 Jan; 54():77-84. PubMed ID: 27915108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging plasmid-encoded colistin resistance: the animal world as the culprit?
    Poirel L; Nordmann P
    J Antimicrob Chemother; 2016 Aug; 71(8):2326-7. PubMed ID: 27029849
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Olaitan AO; Morand S; Rolain JM
    Int J Antimicrob Agents; 2016 Jan; 47(1):1-3. PubMed ID: 26712133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
    Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
    Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin resistance in Gram-negative ocular infections: prevalence, clinical outcome and antibiotic susceptibility patterns.
    Mitra S; Basu S; Rath S; Sahu SK
    Int Ophthalmol; 2020 May; 40(5):1307-1317. PubMed ID: 31984448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mobile colistin-resistance gene variants (
    Ara B; Urmi UL; Haque TA; Nahar S; Rumnaz A; Ali T; Alam MS; Mosaddek ASM; Rahman NAA; Haque M; Islam S
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):513-522. PubMed ID: 33691556
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
    Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
    Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
    [No Abstract]   [Full Text] [Related]  

  • 10. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin resistance landscape: insights into the global spread of mcr-carrying Gram-negative bacteria.
    Zhuang Y; Li X; Wu Y; Jia H; Xie X; Ruan Z
    Int J Antimicrob Agents; 2024 Aug; 64(2):107207. PubMed ID: 38763451
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of faecal carriage of colistin-resistant Gram-negative rods in a university hospital in western France, 2016.
    Saly M; Jayol A; Poirel L; Megraud F; Nordmann P; Dubois V
    J Med Microbiol; 2017 Jun; 66(6):842-843. PubMed ID: 28598315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of infections caused by polymyxin-resistant pathogens.
    Giamarellou H
    Int J Antimicrob Agents; 2016 Dec; 48(6):614-621. PubMed ID: 27865627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of colistin in children.
    Tamma PD; Lee CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):534-5. PubMed ID: 19483519
    [No Abstract]   [Full Text] [Related]  

  • 18. Colistin: still a lifesaver for the 21st century?
    Karaiskos I; Souli M; Galani I; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):59-71. PubMed ID: 27573251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrathecal use of colistin.
    Vasen W; Desmery P; Ilutovich S; Di Martino A
    J Clin Microbiol; 2000 Sep; 38(9):3523. PubMed ID: 11203334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.